The first-quarter 2025 earnings season for the Medical sector is about to pick up pace this week. The sector mainly comprises ...

Parents and Guardians has been urged to increase the scope of proper parenting to their children in order to enable them to ...

Merck MRK will report its first-quarter 2024 earnings on April 24, before market open. The Zacks Consensus Estimate for first ...

Gilead's Trodelvy and Merck's Keytruda improved progression-free survival in PD-L1+ metastatic TNBC in a Phase 3 trial with ...

In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...

Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...

Merck’s stock ticked up 1.9% as analysts threw a mix of “buy” and “hold” ratings like darts at a target. Guggenheim, ...

Several states are reporting cases of measles, a highly contagious viral disease. Both children and adults can get measles.

Merck, Black Hills, and Virtus Investment Partners are good choices for investors seeking reliable passive income. Their ...

U.S. Food and Drug Administration Commissioner Martin Makary announced on Thursday a policy to limit employees of companies ...

Jiangsu Hengrui Pharmaceuticals Co Ltd, a global pharmaceutical company focusing on scientific and technological innovation, announced on March 25 that it has entered into an exclusive license ...

The stock's rise snapped a three-day losing streak.